Rohani-Shukla C

Centre for Psychedelic Research, Imperial College London, London, United Kingdom.

5 papers · 1 preprint

ArticlePsilocybin

On the meaning of "plasticity" in neuroscience and mental health research and its relation to the action of psychedelic therapy.

Carhart-Harris RL, Zeifman RJ, Pasquini L +8

Europe PMC2026
PreprintPsychedelics

On the meaning of ‘plasticity’ in neuroscience and mental health research and its relation to the action of psychedelic therapy

Carhart-Harris R, Zeifman R, Pasquini L +8

Europe PMC2026
ArticlePsilocybin

Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.

Pellegrini L, Fineberg NA, O'Connor S +11

Europe PMC2025
ArticlePsychedelics

Navigating groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences.

Argyri EK, Evans J, Luke D +8

Europe PMC2025
ArticlePsilocybin

Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.

O'Connor S, Godfrey K, Reed S +17

Europe PMC2025
ArticlePsilocybin

Mind over matter: the microbial mindscapes of psychedelics and the gut-brain axis.

Caspani G, Ruffell SGD, Tsang W +4

Europe PMC2024